A central theme unifying the volume is the interconnection between Descartes' philosophical and scientific interests, and the extent to which these two sides of the Cartesian program illuminate each ...

Cartesian Therapeutics has announced updated efficacy and safety data from the Phase IIb trial of its mRNA cell therapy candidate for generalised myasthenia gravis (MG), Descartes-08. The results ...

Rene Descartes’ Cogito, ergo sum – I think, therefore I am – states that thinking is the foundational proof of existence. For Descartes, doubting confirms the presence of a thinking self ...

Cartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or ...

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25Deepening responses observed over time in ...

Ph.D., President and Chief Executive Officer of Cartesian. “With respect to Descartes-08 for the treatment of myasthenia gravis (MG), we recently shared updated Phase 2b results which continue ...

The question of whether thinking alone proves existence or if existence encompasses more than thought takes us into the nature of Being, self-awareness, and life. Rene Descartes' Cogito, ergo sum ...